233 related articles for article (PubMed ID: 26460617)
1. STIP is a critical nuclear scaffolding protein linking USP7 to p53-Mdm2 pathway regulation.
Ye M; Tang Y; Tang S; Liu J; Wu K; Yao S; Sun Y; Zhou L; Deng T; Chen Y; Huang C; Tan W
Oncotarget; 2015 Oct; 6(33):34718-31. PubMed ID: 26460617
[TBL] [Abstract][Full Text] [Related]
2. WDR79 promotes the proliferation of non-small cell lung cancer cells via USP7-mediated regulation of the Mdm2-p53 pathway.
Sun Y; Cao L; Sheng X; Chen J; Zhou Y; Yang C; Deng T; Ma H; Feng P; Liu J; Tan W; Ye M
Cell Death Dis; 2017 Apr; 8(4):e2743. PubMed ID: 28406480
[TBL] [Abstract][Full Text] [Related]
3. USP7 Enforces Heterochromatinization of p53 Target Promoters by Protecting SUV39H1 from MDM2-Mediated Degradation.
Mungamuri SK; Qiao RF; Yao S; Manfredi JJ; Gu W; Aaronson SA
Cell Rep; 2016 Mar; 14(11):2528-37. PubMed ID: 26971997
[TBL] [Abstract][Full Text] [Related]
4. Molecular recognition of p53 and MDM2 by USP7/HAUSP.
Sheng Y; Saridakis V; Sarkari F; Duan S; Wu T; Arrowsmith CH; Frappier L
Nat Struct Mol Biol; 2006 Mar; 13(3):285-91. PubMed ID: 16474402
[TBL] [Abstract][Full Text] [Related]
5. ATM-dependent downregulation of USP7/HAUSP by PPM1G activates p53 response to DNA damage.
Khoronenkova SV; Dianova II; Ternette N; Kessler BM; Parsons JL; Dianov GL
Mol Cell; 2012 Mar; 45(6):801-13. PubMed ID: 22361354
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of USP7/HAUSP activation by its C-terminal ubiquitin-like domain and allosteric regulation by GMP-synthetase.
Faesen AC; Dirac AM; Shanmugham A; Ovaa H; Perrakis A; Sixma TK
Mol Cell; 2011 Oct; 44(1):147-59. PubMed ID: 21981925
[TBL] [Abstract][Full Text] [Related]
7. C-terminal region of USP7/HAUSP is critical for deubiquitination activity and contains a second mdm2/p53 binding site.
Ma J; Martin JD; Xue Y; Lor LA; Kennedy-Wilson KM; Sinnamon RH; Ho TF; Zhang G; Schwartz B; Tummino PJ; Lai Z
Arch Biochem Biophys; 2010 Nov; 503(2):207-12. PubMed ID: 20816748
[TBL] [Abstract][Full Text] [Related]
8. USP7 inhibitor P22077 inhibits neuroblastoma growth via inducing p53-mediated apoptosis.
Fan YH; Cheng J; Vasudevan SA; Dou J; Zhang H; Patel RH; Ma IT; Rojas Y; Zhao Y; Yu Y; Zhang H; Shohet JM; Nuchtern JG; Kim ES; Yang J
Cell Death Dis; 2013 Oct; 4(10):e867. PubMed ID: 24136231
[TBL] [Abstract][Full Text] [Related]
9. The deubiquitinating enzyme USP2a regulates the p53 pathway by targeting Mdm2.
Stevenson LF; Sparks A; Allende-Vega N; Xirodimas DP; Lane DP; Saville MK
EMBO J; 2007 Feb; 26(4):976-86. PubMed ID: 17290220
[TBL] [Abstract][Full Text] [Related]
10. USP7 controls Chk1 protein stability by direct deubiquitination.
Alonso-de Vega I; MartÃn Y; Smits VA
Cell Cycle; 2014; 13(24):3921-6. PubMed ID: 25483066
[TBL] [Abstract][Full Text] [Related]
11. The RNA binding protein RALY suppresses p53 activity and promotes lung tumorigenesis.
Hu H; Zhao K; Fang D; Wang Z; Yu N; Yao B; Liu K; Wang F; Mei Y
Cell Rep; 2023 Apr; 42(4):112288. PubMed ID: 36952348
[TBL] [Abstract][Full Text] [Related]
12. Trip12 is an E3 ubiquitin ligase for USP7/HAUSP involved in the DNA damage response.
Liu X; Yang X; Li Y; Zhao S; Li C; Ma P; Mao B
FEBS Lett; 2016 Dec; 590(23):4213-4222. PubMed ID: 27800609
[TBL] [Abstract][Full Text] [Related]
13. Dynamics in the p53-Mdm2 ubiquitination pathway.
Brooks CL; Gu W
Cell Cycle; 2004 Jul; 3(7):895-9. PubMed ID: 15254415
[TBL] [Abstract][Full Text] [Related]
14. Recent advances on the intervention sites targeting USP7-MDM2-p53 in cancer therapy.
Harakandi C; Nininahazwe L; Xu H; Liu B; He C; Zheng YC; Zhang H
Bioorg Chem; 2021 Nov; 116():105273. PubMed ID: 34474304
[TBL] [Abstract][Full Text] [Related]
15. HAUSP-nucleolin interaction is regulated by p53-Mdm2 complex in response to DNA damage response.
Lim KH; Park JJ; Gu BH; Kim JO; Park SG; Baek KH
Sci Rep; 2015 Aug; 5():12793. PubMed ID: 26238070
[TBL] [Abstract][Full Text] [Related]
16. USP7 modulates UV-induced PCNA monoubiquitination by regulating DNA polymerase eta stability.
Qian J; Pentz K; Zhu Q; Wang Q; He J; Srivastava AK; Wani AA
Oncogene; 2015 Sep; 34(36):4791-6. PubMed ID: 25435364
[TBL] [Abstract][Full Text] [Related]
17. Modulation of the p53/MDM2 interplay by HAUSP inhibitors.
Tavana O; Gu W
J Mol Cell Biol; 2017 Feb; 9(1):45-52. PubMed ID: 27927749
[TBL] [Abstract][Full Text] [Related]
18. Structural basis of competitive recognition of p53 and MDM2 by HAUSP/USP7: implications for the regulation of the p53-MDM2 pathway.
Hu M; Gu L; Li M; Jeffrey PD; Gu W; Shi Y
PLoS Biol; 2006 Feb; 4(2):e27. PubMed ID: 16402859
[TBL] [Abstract][Full Text] [Related]
19. Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells.
Colland F; Formstecher E; Jacq X; Reverdy C; Planquette C; Conrath S; Trouplin V; Bianchi J; Aushev VN; Camonis J; Calabrese A; Borg-Capra C; Sippl W; Collura V; Boissy G; Rain JC; Guedat P; Delansorne R; Daviet L
Mol Cancer Ther; 2009 Aug; 8(8):2286-95. PubMed ID: 19671755
[TBL] [Abstract][Full Text] [Related]
20. HAUSP is required for p53 destabilization.
Cummins JM; Vogelstein B
Cell Cycle; 2004 Jun; 3(6):689-92. PubMed ID: 15118411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
